Objectives

After participating in this educational activity, attendees should be able to:

  1. Review the clinical features of empagliflozin
  2. Define HFpEF
  3. Review previous literature
  4. Review current treatment guidelines for the management of HFpEF
  5. Discuss the methodology and findings of the EMPEROR-Preserve Trial
Faculty
Anna Mortali, PharmD
Pharmacist
PGY1 Community Based Pharmacy Resident
Baystate Medical Center

 

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.

                                                                         

Session date: 
Monday, November 22, 2021 - 2:00pm to 3:00pm
Location: 
Baystate Medical Center
759 Chestnut St.
Live via Webex
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.